Cognition and neurocognition: Effects of risperidone, olanzapine, and haloperidol

American Journal of Psychiatry

Volumn 164, Issue 10, 2007, Pages 1585-1592

  Sergi, Mark J ^a   Green, Michael F ^b   Widmark, Clifford ^b   Reist, Christopher ^b   Erhart, Stephen ^b   Braff, David L ^b   Kee, Kimmy S ^b   Marder, Stephen R ^b   Mintz, Jim ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE; RISPERIDONE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; THINKING; TREATMENT OUTCOME; AMBULATORY CARE; COGNITIVE DEFECT; COMPARATIVE STUDY; EMOTION; FACIAL EXPRESSION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PERCEPTION; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSIS; STATISTICS;

AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COGNITION; COGNITION DISORDERS; EMOTIONS; FACIAL EXPRESSION; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL PERCEPTION; TREATMENT OUTCOME;

EID: 35748959361     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.06091515     Document Type: Article

References (47)

1. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330
2. Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 2000; 26:119-136
3. Adolphs R: The neurobiology of social cognition. Curr Opin Neurobiol 2001; 11:231-239
4. Brothers L: The neural basis of primate social communication. Motivation and Emotion 1990; 14:81-91
5. Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S: Social cognition in schizophrenia: recommendations from the Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference. Schizophr Bull 2005; 31:882-887
6. Penn DL, Addington J, Pinkham A: Social cognitive impairments, in American Psychiatric Association Textbook of Schizophrenia. Edited by Lieberman JA, Stroup TS, Perkins DO. Arlington, Va, American Psychiatric Publishing Press, 2006, pp 261-274
7. Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P: Persecutory delusions: a review and theoretical integration. Clin Psychol Rev 2001; 21:1143-1192
8. Garety PA, Freeman D: Cognitive approaches to delusions: a critical review of theories and evidence. Br J Clin Psychol 1999; 38:113-154
9. Phillips ML, Drevets WC, Rauch SL, Lane R: Neurobiology of emotion perception, II: implications for major psychiatric disorders. Biol Psychiatry 2003; 54:515-528
10. Pinkham AE, Penn DL, Perkins DO, Lieberman J: Implications for a neural basis of social cognition for the study of schizophrenia. Am J Psychiatry 2003; 160:815-824
11. Couture SM, Penn DL, Roberts DL: The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 2006; 32:S44-S63
12. Addington J, Saeedi H, Addington D: Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res 2006; 85:142-150
13. Brekke JS, Kay DD, Kee KS, Green MF: Biosocial pathways to functional outcome in schizophrenia. Schizophr Res 2005; 80:213-225
14. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF: Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry 2006; 163:448-454
15. Vauth R, Rusch N, Wirtz M, Corrigan PW: Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia? Psychiatry Res 2004; 128:155-165
16. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR: Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004; 56:301-307
17. Fiszdon JM, Richardson R, Greig T, Bell MD: A comparison of basic and social cognition between schizophrenia and schizoaffective disorder. Schizophr Res 2007; 91:117-121
18. Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF: Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res 2007; 90:316-324
19. Kee KS, Kern RS, Marshall BD, Green MF: Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophr Res 1998; 31:159-165
20. Littrell KH, Petty RG, Hilligoss NM, Kirshner CD, Johnson CG: Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine. Schizophr Res 2003; 66:201-202
21. Herbener ES, Hill SK, Marvin RW, Sweeney JA: Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. Am J Psychiatry 2005; 162:1746-1748
22. Harvey PD, Patterson TL, Potter LS, Zhong K, Brecher M: Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am J Psychiatry 2006; 163:1918-1925
23. Harvey PD, Keefe RS: Studies of the cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 2001; 158:176-184
24. Woodward ND, Purdon SE, Meltzer HY, Zald DH: A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacology 2005; 8:457-472
25. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002; 159:1018-1028
26. Keefe RSE, Young CA, Rock SL, Purdon SE, Gold JM, Breier A: One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res 2006; 81:1-15
27. Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Washing DA, Liberman RP, Mintz J: The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry 2002; 51:972-978
28. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuno G, Stroup TS, McEvoy JP, Swartz MD, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 2007; 64:633-647
29. Carpenter WT, Gold JM: Another view of therapy for cognition in schizophrenia. Biol Psychiatry 2002; 51:969-971
30. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test (CVLT) Manual. New York, Psychological Corporation, 1983
31. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G: Wisconsin Card Sorting Test (WCST) Manual - Revised and Expanded. Odessa, Fla, PAR, 1993
32. Nuechterlein KH, Asarnow RF: Manual and computer program for the UCLA Continuous Performance Test (Version 5.01A). Los Angeles, UCLA, 1992
33. Gold JA, Carpenter C, Randolph C, Goldberg TE, Weinberger DR: Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997; 54:159-165
34. Matthews CG, Klove H: Instruction Manual for the Adult Neuropsychology Test Battery. Madison, University of Wisconsin Medical School, 1964
35. Benton AL, Hamsher K: Multilingual Aphasia Examination, 2nd ed. Iowa City, Iowa, AJA Associates, 1989
36. First MB, Spitzer RL, Gibbon M, Williams JBW: The Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition. New York, Biometrics Research, 1997
37. Ventura J, Green MF, Shaner A, Liberman RP: Training and quality assurance with the Brief Psychiatric Rating Scale: "the drift busters." Int J Methods Psychiatr Res 1993; 3:221-244
38. Kerr SL, Neale JM: Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J Abnorm Psychol 1993; 102:312-318
39. Izard CE: The Face of Emotion. New York, Appleton-Century-Crofts, 1971
40. Ekman P: Pictures of Facial Affect. Palo Alto, Calif, Consulting Psychologists Press, 1976
41. Ambady N, Hallahan M, Rosenthal R: On judging and being judged accurately in zero-acquaintance situations. J Pers Soc Psychol 1995; 69:519-529
42. Costanzo M, Archer D: The Interpersonal Perception Task - 15 (IPT-15): A Guide for Researchers and Teachers. Berkeley, Calif, University of California Extension, 1993
43. Rosenthal R, Hall JA, DiMatteo MR, Rogers PL, Archer D: Sensitivity to Nonverbal Communication: The PONS Test. Baltimore, Johns Hopkins University Press, 1979
44. Monti PM, Fingeret AL: Social perception and communication skills among schizophrenics and nonschizophrenics. J Clin Psychol 1987; 43:197-205
45. Toomey R, Wallace CJ, Corrigan PW, Schuldberg D, Green MF: Social processing correlates of nonverbal social perception in schizophrenia. Psychiatry 1997; 60:292-300
46. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK: Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72:29-39
47. SAS Institute: SAS/STAT User's Guide, Version 8. Cary NC, SAS Institute, 1999